Patents Assigned to Omega Bio-Pharma (I.P.1) Ltd.
  • Patent number: 8530523
    Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.
    Type: Grant
    Filed: August 28, 2012
    Date of Patent: September 10, 2013
    Assignee: Omega Bio-Pharma (I.P.1) Ltd.
    Inventors: Wen Qin Tang, Francis Chi
  • Patent number: 8258187
    Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.
    Type: Grant
    Filed: September 27, 2010
    Date of Patent: September 4, 2012
    Assignee: Omega Bio-Pharma (I.P.1) Ltd.
    Inventors: Wen Qin Tang, Francis Chi
  • Patent number: 7803843
    Abstract: The subject invention provides materials and methods for improving alcohol metabolism in animals. In a preferred embodiment, the invention provides methods for increasing the ability of people to consume alcohol while reducing hangovers or other effects of intoxication. Specifically exemplified herein is the use of a cysteamine compound to reduce the adverse effects of alcohol consumption. For example, the undesirable and unpleasant symptoms association with hangovers can be reduced through consumption, according to the subject invention, of cysteamine hydrochloride.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: September 28, 2010
    Assignee: Omega Bio-Pharma (I.P.1) Ltd.
    Inventors: Wen Qin Tang, Francis Chi